Global Glass Prefilled Syringe Market Insights and Forecast to 2028

Market Analysis and Insights: Global Glass Prefilled Syringe Market
Due to the COVID-19 pandemic, the global Glass Prefilled Syringe market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Disposable Glass Prefillable Syringe accounting for % of the Glass Prefilled Syringe global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Glass Prefilled Syringe market size is valued at US$ million in 2021, while the US and Europe Glass Prefilled Syringe are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glass Prefilled Syringe landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Glass Prefilled Syringe include BD(US), Roselabs Group(IN), Schott forma vitrum(DE), Baxter BioPharma Solution(US), Terumo(JP), ARTE CORPORATION(JP), Shandong Pharmaceutical Glass(CN), Gerresheimer(DE) and Nipro Corporation(JP), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Glass Prefilled Syringe Scope and Segment
Glass Prefilled Syringe market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Glass Prefilled Syringe market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Disposable Glass Prefillable Syringe
Reuse Glass Pre Filled Syringe
Segment by Application
Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers
By Company
BD(US)
Roselabs Group(IN)
Schott forma vitrum(DE)
Baxter BioPharma Solution(US)
Terumo(JP)
ARTE CORPORATION(JP)
Shandong Pharmaceutical Glass(CN)
Gerresheimer(DE)
Nipro Corporation(JP)
Ompi(IT)
Terumo(JP)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE